Amrutanjan Health Valuation

AMRUTANJAN   699.80  4.70  0.67%   
At this time, the firm appears to be overvalued. Amrutanjan Health Care shows a prevailing Real Value of USD607.86 per share. The current price of the firm is USD699.8. Our model approximates the value of Amrutanjan Health Care from analyzing the firm fundamentals such as Profit Margin of 0.1 %, current valuation of 18.56 B, and Return On Equity of 0.16 as well as examining its technical indicators and probability of bankruptcy.
Price Book
7.0249
Enterprise Value
18.6 B
Enterprise Value Ebitda
25.7173
Price Sales
4.7735
Forward PE
59.8802
Overvalued
Today
699.80
Please note that Amrutanjan Health's price fluctuation is very steady at this time. Calculation of the real value of Amrutanjan Health Care is based on 3 months time horizon. Increasing Amrutanjan Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Amrutanjan Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Amrutanjan Stock. However, Amrutanjan Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  699.8 Real  607.86 Hype  700.95 Naive  706.01
The intrinsic value of Amrutanjan Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Amrutanjan Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
605.74
Downside
607.86
Real Value
769.78
Upside
Estimating the potential upside or downside of Amrutanjan Health Care helps investors to forecast how Amrutanjan stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amrutanjan Health more accurately as focusing exclusively on Amrutanjan Health's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
689.15709.06728.97
Details
Hype
Prediction
LowEstimatedHigh
698.83700.95703.07
Details
Naive
Forecast
LowNext ValueHigh
703.89706.01708.13
Details

Amrutanjan Health Cash

35.26 Million

Amrutanjan Health Total Value Analysis

Amrutanjan Health Care is presently forecasted to have takeover price of 18.56 B with market capitalization of 20.39 B, debt of 17.28 M, and cash on hands of 654.13 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Amrutanjan Health fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
18.56 B
20.39 B
17.28 M
654.13 M

Amrutanjan Health Investor Information

About 59.0% of the company shares are held by company insiders. The company recorded earning per share (EPS) of 16.43. Amrutanjan Health Care last dividend was issued on the 13th of September 2024. The entity had 2:1 split on the 13th of April 2018. Based on the key indicators obtained from Amrutanjan Health's historical financial statements, Amrutanjan Health Care is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.
Current ValueLast YearChange From Last Year 10 Year Trend
Total Cash From Operating Activities216.9 M279.1 M
Significantly Down
Slightly volatile
Operating Income341 M621 M
Way Down
Slightly volatile

Amrutanjan Health Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Amrutanjan Health has an asset utilization ratio of 114.82 percent. This suggests that the Company is making USD1.15 for each dollar of assets. An increasing asset utilization means that Amrutanjan Health Care is more efficient with each dollar of assets it utilizes for everyday operations.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Amrutanjan Health Ownership Allocation

Amrutanjan Health holds a total of 28.9 Million outstanding shares. Amrutanjan Health Care retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Amrutanjan Health Profitability Analysis

The company reported the revenue of 4.21 B. Net Income was 449.73 M with profit before overhead, payroll, taxes, and interest of 1.92 B.

About Amrutanjan Health Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Amrutanjan Health Care. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Amrutanjan Health Care based exclusively on its fundamental and basic technical indicators. By analyzing Amrutanjan Health's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Amrutanjan Health's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Amrutanjan Health. We calculate exposure to Amrutanjan Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Amrutanjan Health's related companies.
Last ReportedProjected for Next Year
Gross Profit2.1 B1.3 B

Amrutanjan Health Quarterly Retained Earnings

2.36 Billion

Other Information on Investing in Amrutanjan Stock

Amrutanjan Health financial ratios help investors to determine whether Amrutanjan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amrutanjan with respect to the benefits of owning Amrutanjan Health security.